Levetiracetam monotherapy for elderly patients with epilepsy

Taoufik M. Alsaadi, Suzanne Koopmans, Michelle L Apperson, Sarah E Tomaszewski Farias

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

We retrospectively identified 14 elderly patients with a history of partial seizures who received levetiracetam (LEV) monotherapy. Patients began LEV either as first line therapy (n = 5) or were converted to LEV monotherapy (n = 9) after failing prior antiepileptic medications (AEDs). Thirteen patients continued on LEV monotherapy for at least 6 months. One patient was lost to follow-up. Eight patients (61.5%) became seizure free. Four patients who began LEV as a first line therapy became seizure free, whereas the remaining four patients who converted to LEV after they failed their previous AEDs became seizure free. Four patients (30.7%) had more than a 50% seizure reduction of seizures. Only one patient had no significant change in seizure frequency after started on LEV. The total dosages used to control seizures were 500-3000 mg/day, (mean 1839.2 mg/day). LEV monotherapy can be effective and well tolerated in this group of patients. A prospective, larger, double blind monotherapy study is needed to confirm this finding.

Original languageEnglish (US)
Pages (from-to)58-60
Number of pages3
JournalSeizure
Volume13
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

etiracetam
Epilepsy
Seizures
Anticonvulsants

Keywords

  • Elderly
  • Levetiracetam
  • Monotherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Psychology(all)

Cite this

Levetiracetam monotherapy for elderly patients with epilepsy. / Alsaadi, Taoufik M.; Koopmans, Suzanne; Apperson, Michelle L; Tomaszewski Farias, Sarah E.

In: Seizure, Vol. 13, No. 1, 01.2004, p. 58-60.

Research output: Contribution to journalArticle

Alsaadi, Taoufik M. ; Koopmans, Suzanne ; Apperson, Michelle L ; Tomaszewski Farias, Sarah E. / Levetiracetam monotherapy for elderly patients with epilepsy. In: Seizure. 2004 ; Vol. 13, No. 1. pp. 58-60.
@article{54c76220f4b742cb869419ef01dcca90,
title = "Levetiracetam monotherapy for elderly patients with epilepsy",
abstract = "We retrospectively identified 14 elderly patients with a history of partial seizures who received levetiracetam (LEV) monotherapy. Patients began LEV either as first line therapy (n = 5) or were converted to LEV monotherapy (n = 9) after failing prior antiepileptic medications (AEDs). Thirteen patients continued on LEV monotherapy for at least 6 months. One patient was lost to follow-up. Eight patients (61.5{\%}) became seizure free. Four patients who began LEV as a first line therapy became seizure free, whereas the remaining four patients who converted to LEV after they failed their previous AEDs became seizure free. Four patients (30.7{\%}) had more than a 50{\%} seizure reduction of seizures. Only one patient had no significant change in seizure frequency after started on LEV. The total dosages used to control seizures were 500-3000 mg/day, (mean 1839.2 mg/day). LEV monotherapy can be effective and well tolerated in this group of patients. A prospective, larger, double blind monotherapy study is needed to confirm this finding.",
keywords = "Elderly, Levetiracetam, Monotherapy",
author = "Alsaadi, {Taoufik M.} and Suzanne Koopmans and Apperson, {Michelle L} and {Tomaszewski Farias}, {Sarah E}",
year = "2004",
month = "1",
doi = "10.1016/S1059-1311(03)00070-0",
language = "English (US)",
volume = "13",
pages = "58--60",
journal = "Seizure : the journal of the British Epilepsy Association",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Levetiracetam monotherapy for elderly patients with epilepsy

AU - Alsaadi, Taoufik M.

AU - Koopmans, Suzanne

AU - Apperson, Michelle L

AU - Tomaszewski Farias, Sarah E

PY - 2004/1

Y1 - 2004/1

N2 - We retrospectively identified 14 elderly patients with a history of partial seizures who received levetiracetam (LEV) monotherapy. Patients began LEV either as first line therapy (n = 5) or were converted to LEV monotherapy (n = 9) after failing prior antiepileptic medications (AEDs). Thirteen patients continued on LEV monotherapy for at least 6 months. One patient was lost to follow-up. Eight patients (61.5%) became seizure free. Four patients who began LEV as a first line therapy became seizure free, whereas the remaining four patients who converted to LEV after they failed their previous AEDs became seizure free. Four patients (30.7%) had more than a 50% seizure reduction of seizures. Only one patient had no significant change in seizure frequency after started on LEV. The total dosages used to control seizures were 500-3000 mg/day, (mean 1839.2 mg/day). LEV monotherapy can be effective and well tolerated in this group of patients. A prospective, larger, double blind monotherapy study is needed to confirm this finding.

AB - We retrospectively identified 14 elderly patients with a history of partial seizures who received levetiracetam (LEV) monotherapy. Patients began LEV either as first line therapy (n = 5) or were converted to LEV monotherapy (n = 9) after failing prior antiepileptic medications (AEDs). Thirteen patients continued on LEV monotherapy for at least 6 months. One patient was lost to follow-up. Eight patients (61.5%) became seizure free. Four patients who began LEV as a first line therapy became seizure free, whereas the remaining four patients who converted to LEV after they failed their previous AEDs became seizure free. Four patients (30.7%) had more than a 50% seizure reduction of seizures. Only one patient had no significant change in seizure frequency after started on LEV. The total dosages used to control seizures were 500-3000 mg/day, (mean 1839.2 mg/day). LEV monotherapy can be effective and well tolerated in this group of patients. A prospective, larger, double blind monotherapy study is needed to confirm this finding.

KW - Elderly

KW - Levetiracetam

KW - Monotherapy

UR - http://www.scopus.com/inward/record.url?scp=0942298810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942298810&partnerID=8YFLogxK

U2 - 10.1016/S1059-1311(03)00070-0

DO - 10.1016/S1059-1311(03)00070-0

M3 - Article

C2 - 14741184

AN - SCOPUS:0942298810

VL - 13

SP - 58

EP - 60

JO - Seizure : the journal of the British Epilepsy Association

JF - Seizure : the journal of the British Epilepsy Association

SN - 1059-1311

IS - 1

ER -